Rarecells Revenue and Competitors
Estimated Revenue & Valuation
- Rarecells's estimated annual revenue is currently $2M per year.
- Rarecells's estimated revenue per employee is $77,500
- Rarecells's total funding is $13M.
Employee Data
- Rarecells has 26 Employees.
- Rarecells grew their employee count by 18% last year.
Rarecells's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | President & Founder | Reveal Email/Phone |
3 | Research Laboratory Technician | Reveal Email/Phone |
4 | Bio-informatic scientist | Reveal Email/Phone |
5 | Deputy CEO | Reveal Email/Phone |
6 | Technicien médical | Reveal Email/Phone |
7 | Technicienne de laboratoire | Reveal Email/Phone |
8 | Responsable Logistique et Administrative | Reveal Email/Phone |
9 | Responsable de projet de Recherche et Developpement | Reveal Email/Phone |
Rarecells Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Rarecells?
Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique Hôpitaux de Paris and INSERM protecting the Rarecells® Device and its consumables, as well as the analyses performed on cells isolated using the Rarecells® System. Rarecells® Diagnostics is a science-driven company. We are scientists working for scientists and patients. We care about bringing benefits to the patients.The team delivers customer satisfaction by manufacturing high quality products and providing high-level scientific assistance. Rarecells® and ISET® are registered trademarks of Rarecells SAS.
keywords:N/A
$13M
Total Funding
26
Number of Employees
$2M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rarecells News
This suggested to the researchers that these rare cells may be present even before treatment. "The alterations to the epithelium and...
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 26 | 0% | N/A |
#2 | $2.6M | 26 | -16% | N/A |
#3 | $2.6M | 26 | N/A | N/A |
#4 | $2.5M | 26 | N/A | N/A |
#5 | $1.8M | 26 | 4% | N/A |